SCHEMBL30817138

SCHEMBL30817138

O=C(O)c1cc2cc3c(cc2[nH]1)OCO3

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.56
CA2 P00918 1/20 0.51
SMAD3 P84022 1/20 0.49
KDM4E B2RXH2 7/20 0.47
HPGD P15428 5/20 0.47
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 2/20 0.47
F7 P08709 1/20 0.47
F3 P13726 1/20 0.47
PIN1 Q13526 1/20 0.47
PDPK1 O15530 1/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
APEX1 P27695 1/20 0.47
CYP2C19 P33261 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MAPT P10636 3/20 0.47
DAO P14920 2/20 0.47
SRD5A2 P31213 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2400125 1.00 GPR35 (0.56) GPR35CA2SMAD3KDM4EHPGD
SCHEMBL13174693 0.90 GPR35 (0.56) GPR35CA2SMAD3KDM4EHPGD
SCHEMBL13174691 0.87 GPR35 (0.53) GPR35CA2SMAD3KDM4EHPGD
SCHEMBL16821915 0.85 CA2 (0.54) GPR35CA2KDM4EHPGDALDH1A1
SCHEMBL5716697 0.82 RAB9A (0.56) CA2KDM4EHPGDALDH1A1LMNA
SCHEMBL16795765 0.81 CA2 (0.47) CA2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL8985814 0.81 KDM4E (0.49) CA2KDM4EHPGDALDH1A1HSD17B10
SCHEMBL20495106 0.81 KDM4E (0.51) GPR35KDM4EHPGDALDH1A1HSD17B10
SCHEMBL11433959 0.79 KDM4E (0.51) GPR35KDM4EHPGDALDH1A1HSD17B10
SCHEMBL10910498 0.77 KDM4E (0.60) KDM4EHPGDALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587433-A1 3-(1H-INDOLE-2-CARBONYL)-6,6-DIMETHYL-N-((S)-1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)P ROPAN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE DERIVATIVES AS MPRO INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS Takeda Pharmaceutical Company Limited (JP) 2025-07-23 EP disclosed
WO-2024059087-A1 3-(1H-INDOLE-2-CARBONYL)-6,6-DIMETHYL-N-((S)-1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)P ROPAN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE DERIVATIVES AS MPRO INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-03-21 WO disclosed